Medpace Holdings, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Medpace Holdings, Inc. (MEDP), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are MEDP insiders buying or selling?
In the last 12 months, Medpace Holdings, Inc. insiders reported 0 open-market purchases ($0) and 39 sales ($467.0M) — net selling of $467.0M. Since May 2018, Trabud has recorded 318 Form 4 filings for MEDP: 22 buys ($309.2M) and 296 sells ($3.5B).
Source: SEC EDGAR Form 4
What stands out
- No Medpace Holdings, Inc. insider made an open-market purchase in the last 12 months; the 39 reported open-market sales totaled $467.0M.
Key Statistics (May 2018 – Oct 1, 2026)
Total Form 4 filings
318
SEC EDGAR
Insider filers
13
Insider buys (22)
$309.2M
Insider sells (296)
$3.5B
Insider sentiment
Net sellingNet insider flow of $3.2B in net selling since May 2018, and $467.0M in net selling over the last 12 months.
Recent MEDP insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | August J. Troendle | President & CEO | Sale | 48.7K | $623.03 | $30.3M | SEC ↗ |
| Sep 29, 2026 | August J. Troendle | President & CEO | Sale | 2.6K | $620.10 | $1.6M | SEC ↗ |
| Sep 25, 2026 | August J. Troendle | President & CEO | Sale | 43.9K | $624.01 | $27.4M | SEC ↗ |
| Sep 23, 2026 | August J. Troendle | President & CEO | Sale | 70.9K | $626.62 | $44.4M | SEC ↗ |
| Sep 21, 2026 | August J. Troendle | President & CEO | Sale | 10.9K | $620.40 | $6.7M | SEC ↗ |
| Sep 17, 2026 | August J. Troendle | President & CEO | Sale | 24.7K | $621.00 | $15.4M | SEC ↗ |
| Aug 31, 2026 | August J. Troendle | President & CEO | Sale | 650 | $620.27 | $403.2K | SEC ↗ |
| Aug 28, 2026 | Robert O. Kraft | Director | Sale | 3.9K | $617.81 | $2.4M | SEC ↗ |
| Aug 27, 2026 | August J. Troendle | President & CEO | Sale | 4.7K | $620.08 | $2.9M | SEC ↗ |
| Aug 25, 2026 | August J. Troendle | President & CEO | Sale | 16.0K | $623.93 | $10.0M | SEC ↗ |
| Aug 24, 2026 | Kevin M. Brady | CFO & Treasurer | Sale | 3.4K | $625.24 | $2.1M | SEC ↗ |
| Aug 21, 2026 | August J. Troendle | President & CEO | Sale | 42.8K | $614.30 | $26.3M | SEC ↗ |
| Aug 21, 2026 | Brian T Carley | Director | Sale | 5.0K | $608.63 | $3.0M | SEC ↗ |
| Aug 21, 2026 | Fred B Davenport JR | Director | Sale | 7.3K | $606.15 | $4.4M | SEC ↗ |
| Aug 14, 2026 | August J. Troendle | President & CEO | Sale | 11.8K | $601.49 | $7.1M | SEC ↗ |
| Aug 13, 2026 | Cornelius P. Mccarthy III | Director | Sale | 1.1K | $605.37 | $690.1K | SEC ↗ |
| Aug 12, 2026 | August J. Troendle | President & CEO | Sale | 23.1K | $604.25 | $14.0M | SEC ↗ |
| Aug 11, 2026 | Cornelius P. Mccarthy III | Director | Sale | 795 | $585.07 | $465.1K | SEC ↗ |
| Jul 29, 2026 | August J. Troendle | President & CEO | Sale | 7.2K | $600.44 | $4.3M | SEC ↗ |
| Jul 29, 2026 | Susan E Burwig | Exec. VP, Operations | Sale | 7.5K | $600.00 | $4.5M | SEC ↗ |
| Jun 1, 2026 | Stephen P Ewald | General Counsel & Corp. Secy. | Sale | 16.3K | $450.00 | $7.4M | SEC ↗ |
| Mar 19, 2026 | Jesse J Geiger | President | Sale | 31.7K | $455.30 | $14.4M | SEC ↗ |
| Dec 4, 2025 | August J. Troendle | CEO | Sale | 668 | $590.69 | $394.6K | SEC ↗ |
| Dec 3, 2025 | August J. Troendle | CEO | Sale | 28.9K | $592.70 | $17.1M | SEC ↗ |
| Dec 1, 2025 | August J. Troendle | CEO | Sale | 56.5K | $603.28 | $34.1M | SEC ↗ |
Showing the 25 most recent of 318 Form 4 filings for Medpace Holdings, Inc..
Most active MEDP insiders
- August J. Troendle138 filings
- Medpace Investors, LLC102 filings
- Jesse J Geiger17 filings
- Stephen P Ewald14 filings
- Susan E Burwig14 filings
Ask anything about MEDP insider activity
Use Trabud's AI agent to query Medpace Holdings, Inc.'s Form 4 history in plain English — "Show me MEDP CEO purchases this year" or compare it against any other ticker.
Open the AI agentMEDP insider trading FAQ
Are Medpace Holdings, Inc. insiders buying or selling?
In the last 12 months, Medpace Holdings, Inc. insiders reported 0 open-market purchases ($0) and 39 sales ($467.0M) — net selling of $467.0M. Since May 2018, Trabud has recorded 318 Form 4 filings for MEDP: 22 buys ($309.2M) and 296 sells ($3.5B). Over the full record that is net selling of $3.2B.
How many insiders trade MEDP stock?
13 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Medpace Holdings, Inc.. The most recent filing was accepted on Oct 1, 2026.
Where does Trabud get MEDP insider trading data?
All MEDP insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.